FHL-4 Antibodies

Santa Cruz Biotechnology provides a broad selection of FHL-4 monoclonal antibodies for research applications. FHL-4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FHL-4, or Four and a Half LIM Domains 4, is a protein that plays a significant role in cellular signaling and development. FHL-4 participates in the regulation of gene expression and influences various biological processes. Research has shown FHL-4's involvement in muscle differentiation and cardiac development. Understanding FHL-4 function continues to be a key focus in both health and disease research. Scientists studying cellular biology can rely on FHL-4 monoclonal antibodies to advance their research projects. FHL-4 monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their pursuit of scientific discoveries and medical breakthroughs.